F. Berger

1.8k total citations
75 papers, 1.2k citations indexed

About

F. Berger is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, F. Berger has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 17 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in F. Berger's work include Cardiac electrophysiology and arrhythmias (19 papers), Hepatitis C virus research (14 papers) and Ion channel regulation and function (13 papers). F. Berger is often cited by papers focused on Cardiac electrophysiology and arrhythmias (19 papers), Hepatitis C virus research (14 papers) and Ion channel regulation and function (13 papers). F. Berger collaborates with scholars based in Germany, France and Switzerland. F. Berger's co-authors include Stefan Mauss, U. Borchard, D. Häfner, Guenther Schmutz, Caroline Gutjahr, G Schmutz, D. Hueppe, Juergen Rockstroh, Thomas A. Lutz and P Hegener and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Hepatology.

In The Last Decade

F. Berger

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Berger Germany 19 541 486 262 210 191 75 1.2k
Makoto Kako Japan 19 814 1.5× 831 1.7× 128 0.5× 69 0.3× 97 0.5× 88 1.4k
Rakesh Kumar Vasishta India 17 269 0.5× 199 0.4× 86 0.3× 52 0.2× 138 0.7× 65 1.0k
Varsha Thakur India 20 847 1.6× 588 1.2× 61 0.2× 102 0.5× 118 0.6× 53 1.3k
Wolfgang Jessner Austria 17 713 1.3× 820 1.7× 117 0.4× 51 0.2× 143 0.7× 50 1.2k
Ching‐Sheng Hsu Taiwan 24 1.1k 2.1× 1.1k 2.2× 67 0.3× 70 0.3× 172 0.9× 70 1.8k
Sebastian Seidler Germany 6 383 0.7× 323 0.7× 46 0.2× 37 0.2× 138 0.7× 7 893
Jeffery L. Steers United States 29 1.0k 1.9× 1.3k 2.6× 148 0.6× 43 0.2× 190 1.0× 64 2.3k
Gabriella Di Lorenzo Italy 12 396 0.7× 351 0.7× 144 0.5× 94 0.4× 64 0.3× 14 751
Wenhua He China 21 304 0.6× 54 0.1× 63 0.2× 229 1.1× 272 1.4× 94 1.5k
Jérôme Guechot France 21 837 1.5× 716 1.5× 42 0.2× 10 0.0× 228 1.2× 49 1.5k

Countries citing papers authored by F. Berger

Since Specialization
Citations

This map shows the geographic impact of F. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Berger more than expected).

Fields of papers citing papers by F. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Berger. The network helps show where F. Berger may publish in the future.

Co-authorship network of co-authors of F. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of F. Berger. A scholar is included among the top collaborators of F. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Berger. F. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, F., Patrick Badertscher, Michael Kühne, et al.. (2025). Percutaneous left atrial appendage occluders can impair pulmonary vein isolation by pulsed field ablation. Heart Rhythm. 22(9). e801–e803. 1 indexed citations
2.
Saguner, Ardan M., F. Berger, Matthias Gass, et al.. (2023). A desmoplakin variant associated with isolated arrhythmogenic left ventricular cardiomyopathy with rapid monomorphic ventricular tachycardia at first presentation. HeartRhythm Case Reports. 9(6). 406–409. 2 indexed citations
4.
Berger, F., et al.. (2022). Physical Activity in Fontan Patients Relates to Quality of Life and Sleep Quality. Frontiers in Cardiovascular Medicine. 9. 915810–915810. 5 indexed citations
5.
Berger, F. & Caroline Gutjahr. (2021). Factors affecting plant responsiveness to arbuscular mycorrhiza. Current Opinion in Plant Biology. 59. 101994–101994. 66 indexed citations
6.
Kottmaier, Marc, Félix Bourier, Tilko Reents, et al.. (2020). Atrial fibrillation ablation in adults with congenital heart disease on uninterrupted oral anticoagulation is safe and efficient. Clinical Research in Cardiology. 109(7). 904–910. 4 indexed citations
7.
Milinkovic, Ana, F. Berger, Alejandro Arenas‐Pinto, & Stefan Mauss. (2019). Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back. AIDS. 33(15). 2387–2391. 41 indexed citations
8.
Berger, F., Nils G. Morgenthaler, Hans Ulrich Bucher, et al.. (2011). Plasma C-Terminal Pro-Endothelin-1 and the Natriuretic Pro-Peptides NT-proBNP and MR-proANP in Very Preterm Infants with Patent Ductus Arteriosus. Neonatology. 101(2). 116–124. 18 indexed citations
9.
Schmutz, Guenther, Mark Nelson, Thomas A. Lutz, et al.. (2006). Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. AIDS. 20(15). 1951–1954. 66 indexed citations
10.
Mauss, S, Stefan Scholten, Eva Wolf, et al.. (2004). A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. HIV Medicine. 5(1). 15–17. 8 indexed citations
11.
Mauss, Stefan, et al.. (2004). A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology. 40(1). 120–124. 128 indexed citations
12.
Mauss, Stefan, et al.. (2003). Differentiating hyperlipidaemia associated with antiretroviral therapy. AIDS. 17(2). 189–194. 21 indexed citations
13.
Berger, F., Ingo Dähnert, Erik Thaulow, et al.. (1998). Interventional closure of atrial septal defects with the Amplatzer™ device in children and adults. Journal of the American College of Cardiology. 31. 153–153. 1 indexed citations
14.
Berger, F., et al.. (1998). Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(3). 291–298. 11 indexed citations
15.
Borchard, U., F. Berger, D. Häfner, Derik Hermsen, & O. Picker. (1997). Elektrophysiologische Wirkungen von K+ und Mg2+ im Hypoxiemodell. Herz. 22(S1). 28–35.
16.
Thomé, Ulrich, F. Berger, U. Borchard, & D. Häfner. (1997). Modulation of pacemaker activity in sheep cardiac Purkinje fibers by stimulation of ?-adrenoceptor subtypes. Basic Research in Cardiology. 92(1). 25–34. 6 indexed citations
17.
Berger, F., et al.. (1995). Inhibition of pacemaker current by the bradycardic agent ZD 7288 is lost use-dependently in sheep cardiac Purkinje fibres. Naunyn-Schmiedeberg s Archives of Pharmacology. 353(1). 64–72. 6 indexed citations
18.
Berger, F., et al.. (1994). Effects of the bradycardic agent ZD 7288 on membrane voltage and pacemaker current in sheep cardiac Purkinje fibres. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 677–84. 9 indexed citations
19.
Berger, F., et al.. (1993). A slowly inactivating transient outward current in rat ventricular myocytes. Pflügers Archiv - European Journal of Physiology. 425(1-2). 184–186. 7 indexed citations
20.
Häfner, D., et al.. (1988). Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.. PubMed. 38(2). 231–6. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026